EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieOpen Access

Development and Validation of a Mortality Risk Score for Repaired Tetralogy of Fallot

Joshua Mayourian, Lynn A Sleeper iD, Ji Hae Lee iD, Minmin Lu, Alon Geva iD, Barbara Mulder, Sonya V Babu-Narayan iD, Rachel M Wald iD, Tehila Sompolinsky iD, Anne Marie Valente iD, Tal Geva iD

Journal of the American Heart Association · 18.06.2024 · 13 (12)

DOI: 10.1161/jaha.123.034871 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 18.06.2024. Verfasst von Joshua Mayourian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Boston Children's Hospital, Department of Pediatrics Harvard Medical School Boston MA USA. Hauptthemen laut MEDLINE: Tetralogy of Fallot, Registries. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Robust risk assessment is crucial for the growing repaired tetralogy of Fallot population at risk of major adverse clinical outcomes; however, current tools are hindered by lack of validation. This study aims to develop and validate a risk prediction model for death in the repaired tetralogy of Fallot population. Methods and Results Patients with repaired tetralogy of Fallot enrolled in the INDICATOR (International Multicenter Tetralogy of Fallot Registry) cohort with clinical, arrhythmia, cardiac magnetic resonance, and outcome data were included. Patients from London, Amsterdam, and Boston sites were placed in the development cohort; patients from the Toronto site were used for external validation. Multivariable Cox regression was used to evaluate factors associated with time from cardiac magnetic resonance until the primary outcome: all‐cause death. Of 1552 eligible patients (n=1221 in development, n=331 in validation; median age at cardiac magnetic resonance 23.4 [interquartile range, 15.6–35.6] years; median follow up 9.5 years), 102 (6.6%) experienced the primary outcome. The multivariable Cox model performed similarly during development (concordance index, 0.83 [95% CI, 0.78–0.88]) and external validation (concordance index, 0.80 [95% CI, 0.71–0.90]) and identified older age at cardiac magnetic resonance, obesity, type of tetralogy of Fallot repair, higher right ventricular end‐systolic volume index, and lower biventricular global function index as independent predictors of death. A risk‐scoring algorithm dividing patients into low‐risk (score ≤4) versus high‐risk (score >4) groups was validated to effectively discriminate risk of death (15‐year survival of 95% versus 74%, respectively; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tetralogy of FallotRegistriesHumansMaleFemaleRisk AssessmentAdultAdolescentYoung AdultRisk FactorsCardiac Surgical ProceduresReproducibility of ResultsTime FactorsPredictive Value of TestsCause of Death

Stichwörter der Autor:innen

cardiovascular magnetic resonancecongenital heart diseasedeathoutcomesrisk scoretetralogy of Fallotventricular function

Autor:innen und Institutionen

  • Department of Cardiology, Boston Children's Hospital, Department of Pediatrics Harvard Medical School Boston MA USA.
  • Department of Anesthesiology, Critical Care, and Pain Medicine, and Computational Health Informatics Program, Boston Children's Hospital and Department of Anaesthesia Harvard Medical School Boston MA USA.
  • Department of Cardiology Amsterdam University Medical Centre Amsterdam The Netherlands.
  • Royal Brompton and Harefield NHS Foundation Trust National Heart and Lung Institute, Imperial College London United Kingdom.
  • Division of Cardiology University of Toronto, Peter Munk Cardiac Centre Toronto ON Canada.

ORCID-Profile: Lynn A Sleeper, Ji Hae Lee, Alon Geva, Sonya V Babu-Narayan, Rachel M Wald, Tehila Sompolinsky, Anne Marie Valente, Tal Geva

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Mayourian, J., Sleeper, L. A., Lee, J. H., Lu, M., Geva, A., Mulder, B., Babu-Narayan, S. V., Wald, R. M., Sompolinsky, T., Valente, A. M., & Geva, T. (2024). Development and Validation of a Mortality Risk Score for Repaired Tetralogy of Fallot. Journal of the American Heart Association, 13(12). https://doi.org/10.1161/jaha.123.034871

Vancouver

Mayourian J, Sleeper LA, Lee JH, Lu M, Geva A, Mulder B, et al. Development and Validation of a Mortality Risk Score for Repaired Tetralogy of Fallot. Journal of the American Heart Association. 2024;13(12). doi:10.1161/jaha.123.034871

BibTeX
@article{Mayourian2024,
  author = {Mayourian, Joshua and Sleeper, Lynn A and Lee, Ji Hae and Lu, Minmin and Geva, Alon and Mulder, Barbara and Babu-Narayan, Sonya V and Wald, Rachel M and Sompolinsky, Tehila and Valente, Anne Marie and Geva, Tal},
  title = {Development and Validation of a Mortality Risk Score for Repaired Tetralogy of Fallot},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {12},
  doi = {10.1161/jaha.123.034871}
}
Kostenlos starten →